M&T Bank
PRQR icon

M&T Bank’s ProQR Therapeutics PRQR Stock Holding History

M&T Bank’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-124,770
Closed -$330K – 1652
2024
Q4 		$330K Buy
+124,770
New +$396K ﹤0.01% 1339
2016
Q4 		– Sell
-12,416
Closed -$83K – 1744
2016
Q3 		$83K Buy
+12,416
New +$68.3K ﹤0.01% 1565
2016
Q2 		– Sell
-11,300
Closed -$55K – 1755
2016
Q1 		$55K Hold
11,300
– – ﹤0.01% 1591
2015
Q4 		$98K Buy
+11,300
New +$130K ﹤0.01% 1578

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

M&T Bank's PRQR Position: Q1 2025 in Review

M&T Bank sold out of ProQR Therapeutics (PRQR) in Q1 2025, closing a stake of 124,770 shares — an estimated $330K sold.

M&T Bank first reported a position in PRQR in Q4 2015 and held it in 4 quarters. The position peaked at $330K in Q4 2024. 65 funds tracked by Wall St. Rank hold PRQR as of Q1 2025.

  • M&T Bank reported no remaining ProQR Therapeutics position as of Q1 2025 after selling out during the quarter.
  • M&T Bank sold 124,770 ProQR Therapeutics shares in Q1 2025, an estimated $330K.
  • M&T Bank first reported a position in ProQR Therapeutics in Q4 2015 and held it in 4 quarters.
  • M&T Bank's ProQR Therapeutics position peaked at $330K in Q4 2024.
  • 65 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2025.

Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.